おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Sciwind Biosciences
company
About
Sciwind Biosciences is a drug research and development company for metabolic diseases.
- 51 - 100
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- ¥450M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2017
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Sciwind Biosciences is a developers of drugs intended to treat metabolic disorders. The company's drugs contain protein and peptide candidates for non-alcoholic steatohepatitis, enabling physicians to treat their patients in an enhanced way.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥450M
Sciwind Biosciences has raised a total of
¥450M
in funding over 2 rounds. Their latest funding was raised on
Oct 11, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 11, 2021 | Series C | ¥450M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Sciwind Biosciences is funded by 1 investors.
Zhengxingu Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
